EDF Health

Selected tag(s): Formaldehyde

EPA to release assessment of toxic formaldehyde, rejects industry’s tired delay tactics

By Maria Doa, PhD, Senior Director, Chemicals Policy / Published: April 13, 2022

Maria Doa, Ph.D., Senior Director, Chemicals Policy 

The EPA will release a draft Integrated Risk Information System (IRIS) assessment of formaldehyde, a key scientific review that identifies and characterizes the hazards from chronic exposure to this known carcinogen. The draft assessment, due to be published tomorrow, will be reviewed by the National Academies of Science, Engineering and Medicine (National Academies).

We welcome the EPA’s decision to issue its formaldehyde assessment. Release of the assessment is a win for scientific integrity that follows years of pressure from industry groups and efforts during the previous administration to suppress the assessment. 

The EPA’s IRIS program is the gold standard for identifying and characterizing the hazards that result from exposure to chemicals. Its findings are essential to informing health-based standards that protect frontline communities, workers, children, consumers and more.   Read More »

Posted in Health policy, Health science, Industry influence, Public health / Also tagged , , | Comments are closed

Wheeler piles on more deception trying to defend EPA’s corrupt actions on formaldehyde

By / Published: April 10, 2019

Richard Denison, Ph.D., is a Lead Senior Scientist.

In a series of recent hearings Environmental Protection Agency (EPA) Administrator Andrew Wheeler has sought to justify his and his agency’s corrupt decisions to kill off a health assessment of formaldehyde done by career scientists in the agency’s science arm (IRIS) and resurrect it under the control of conflicted political appointees.[pullquote]Once again, the Trump EPA is elevating private interests over the public interest – and offering up deceptions to try to obfuscate and cover up its real intent.[/pullquote]

Recall that under Wheeler’s and his predecessor’s leadership, a draft of the IRIS assessment, ready since fall 2017 for release for public comment and peer review, has been suppressed.  Also recall that EPA leadership ran a phony priority-setting process last fall under the direction of yet another conflicted political appointee in order to claim that the IRIS formaldehyde assessment is no longer a priority for the agency.  Aspects of this scheme were highlighted in a recent report of Congress’ Government Accountability Office (GAO).  Finally, recall that a scant few weeks after that pronouncement, EPA declared last month that it intends to name formaldehyde a “high-priority substance” under TSCA.

Now to the next installment in this corrupt scheme:  Read More »

Posted in Health policy, Industry influence / Also tagged | Comments are closed

EPA’s Naming of Formaldehyde as a Candidate for High Priority Under TSCA Raises Serious Concerns

By EDF Blogs / Published: March 20, 2019

Statement of Dr. Richard Denison, Lead Senior Scientist at Environmental Defense Fund 

“EPA’s statement today regarding its inclusion of formaldehyde on the list of chemicals under consideration for prioritization for risk evaluation under TSCA leaves many questions unanswered.

EPA states that ‘the work done for IRIS will inform the TSCA process.’ Such consideration is already required by law.

What is absolutely essential is that the IRIS program be able to complete its assessment of formaldehyde, which has been suppressed for the last year and a half by conflicted EPA political appointees.  Then EPA’s TSCA office, just like every other EPA office, can and should rely on it to make regulatory decisions.

It’s time that political interference in the agency’s science stop.”

For more information see the following EDF blog post: The Trump EPA’s actions on formaldehyde can be summed up in one word: Corrupt.

Posted in Health policy, Health science, Public health, TSCA reform / Also tagged | Comments are closed

GAO affirms the Trump EPA’s political manipulation of the IRIS formaldehyde assessment

By / Published: March 7, 2019

Richard Denison, Ph.D., is a Lead Senior Scientist.

I blogged last month about the Trump EPA’s corrupt actions to bury the long-awaited assessment of the carcinogen formaldehyde conducted by the agency’s Integrated Risk Information System (IRIS) program.  That post cited an article in the Wall Street Journal that noted a forthcoming report by Congress’ Government Accountability Office (GAO) that was expected to expose the suspect process used by conflicted political appointees at EPA to prevent public release and completion of that scientific assessment over the past 15 months.  We also noted disturbing indications that EPA intends to redo the assessment of formaldehyde under the Toxic Substances Control Act (TSCA), under the control of political appointees who came to EPA directly from the chemical industry’s main trade association and while there led its efforts to undermine IRIS. [pullquote]GAO confirms in spades the concerted efforts by the agency’s political leadership to fabricate a rationale for abandoning the formaldehyde assessment, which has been ready for public and peer review since the fall of 2017.[/pullquote]

GAO’s report is out, and yesterday it featured prominently at a Senate hearing at which top GAO officials testified.  That testimony confirms in spades the recounting in our earlier blog post of the concerted efforts by the agency’s political leadership to fabricate a rationale for abandoning the formaldehyde assessment, which has been ready for public and peer review since the fall of 2017.

In the wake of the GAO report, Senator Carper and other members of Congress from both houses have sent a letter to EPA Administrator Andrew Wheeler calling on him to complete the formaldehyde assessment and release documents pertaining to potential ethical and scientific integrity policy violations by EPA political appointees.

I won’t further rehash our earlier post, but will simply post a key excerpt from the hearing, an exchange between Senator Tom Carper (DE) and Mark Gaffigan, Managing Director for Natural Resources and Environment at GAO.  I’ll highlight some key passages in which GAO describes what its investigation found.

EXCERPT FROM YESTERDAY’S GAO TESTIMONY   Read More »

Posted in Health policy, Health science, Industry influence / Also tagged , | Comments are closed

The Trump EPA’s actions on formaldehyde can be summed up in one word: Corrupt

By / Published: February 14, 2019

Richard Denison, Ph.D., is a Lead Senior Scientist.

Today, Heidi Vogt at the Wall Street Journal reported on the systematic efforts by the Trump Administration to derail chemical assessments under the Environmental Protection Agency’s (EPA) Integrated Risk Information System (IRIS).   [pullquote]Decisions are being made as I write by conflicted EPA political appointees, not only to derail the beleaguered IRIS assessment for the carcinogen formaldehyde, but to transfer any further assessment of the chemical to be under the control of those same political appointees.[/pullquote]

The WSJ article cites an upcoming report by Congress’ Government Accountability Office (GAO) that notes “EPA leadership in October directed the heads of the agency’s various programs to limit the number of chemicals they wanted IRIS to study or continue researching.  Nine of 16 assessments were then dropped, including one that looked at whether exposure to formaldehyde increases the risk of leukemia that ‘has been drafted and is ready to be released for public comment.’ ”  The chemical industry has long sought to undermine the findings of numerous governmental authorities that have identified the dangers posed by formaldehyde, one of the industry’s biggest cash cows.

IRIS itself has also long been a target of the chemical and allied industries, including those well represented by EPA political appointees who are now able to drive the assault on IRIS from inside the agency.

This post will provide more of the backstory to the WSJ’s excellent reporting.  It reveals additional decisions being made as I write by conflicted political appointees, not only to derail the beleaguered IRIS assessment for formaldehyde, a known human carcinogen, but to transfer any further assessment of the chemical to be under the control of those same political appointees.  What is happening here we believe is ripe for further investigation.   Read More »

Posted in Health policy, Health science, Industry influence, TSCA reform / Also tagged , , , | Read 1 Response

Formaldehyde delay rule – another defeat for Trump EPA

By Tom Neltner, Senior Director, Safer Chemicals Initiative / Published: February 20, 2018

Tom Neltner, J.D., is Chemicals Policy Director

March 17, 2018 update: The court ordered EPA’s rule vacated as of June 1, 2018 based on an agreement by the parties.  This rule would have delayed the compliance deadline for the formaldehyde from composite wood products rule from 12/12/17 by one year.  The parties agreed that until March 22, 2019, products certified as compliant by the California Air Resources Board is sufficient to comply with EPA’s rule. EPA has updated its webpage to provide details. The parties reserved their right to appeal the order.

On February 16, the Trump Administration’s Environmental Protection Agency (EPA) suffered another defeat in the courts.

In the latest case, the United States District Court for Northern California found that EPA violated the law when it gave industry a one-year delay to comply with formaldehyde emission standard for composite wood products. The standard was supposed to go into effect on December 12, 2017, one year after it was published in the Federal Register. Administrator Pruitt originally proposed a three month delay because, with the change in Administration, the agency failed to make a certification program essential to industry compliance operational, as originally planned. On September 25, 2017, the agency issued a final rule that gave a one-year extension instead, concluding that the delay “provides a balanced and reasoned timeline for importers, distributors, and regulated entities to establish compliant supply chain and comply with the [rule].” It also extended other deadlines in the rule.

Read More »

Posted in Health policy, Public health / Also tagged , | Comments are closed